Patient engagement: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} | ||
==Overview== | ==Overview== | ||
As technology continues to advance, physicians are looking for new ways to engage patients in their own health utilizing smartphone and tablet technology. Multiple randomized control studies have been performed to evaluate whether | As technology continues to advance, physicians are looking for new ways to engage patients in their own health utilizing smartphone and tablet technology. Multiple randomized control studies have been performed to evaluate whether mobile health has an impact on chronic healthcare conditions, such as diabetes, hypertension, and obesity. The data is mixed, but a several recent trials have shown promise. | ||
==Patient Engagement / Participation== | ==Patient Engagement / Participation== | ||
Mobile Health | |||
Mobile phone text messaging approximately doubles the odds of medication adherence. A meta- analysis was conducted of 16 randomized control trials to assess the effect of mobile phone text messaging on medication adherence in the setting chronic disease. Study concluded that this intervention improved adherence rates from 50% to 67.8% or an absolute increase of 17.8% (PMID: 26831740). | |||
Mobile health technology has been shown to have a greater reduction in hemoglobin A1c in the setting of diabetes. A randomized controlled trial evaluating the effectiveness of simultaneous mobile health technology in use of diabetes care, when initiating basal insulin therapy, showed a greater reduction in A1c level compared with standard therapy of basal insulin (3.2 ± 1.5% vs. 2.0% ± 2.0%; P = 0.048). This study suggests the use of mobile technology may be an effective form of communication between patients and providers and increase active patient engagement in their health (PMID: 26645932). | |||
==References== | ==References== | ||
{{Reflist|2 Utilization of a Cloud-Based Diabetes }}Hsu, William C. MD. Utilization of a Cloud-Based Diabetes Management Program for Insulin Initiation and Titration Enables Collaborative Decision Making Between Healthcare Providers and Patients''. Diabetes Technology & Therapeutics,'' 18(2), 59-67. DOI: 10.1089/dia.2015.0160. | {{Reflist|2 Utilization of a Cloud-Based Diabetes }}Hsu, William C. MD. Utilization of a Cloud-Based Diabetes Management Program for Insulin Initiation and Titration Enables Collaborative Decision Making Between Healthcare Providers and Patients''. Diabetes Technology & Therapeutics,'' 18(2), 59-67. DOI: 10.1089/dia.2015.0160. | ||
Thakkar, Jay FRACP, Kurup,Rahul MBBS. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease A Meta-Analysis. ''JAMA Intern Med'', | Thakkar, Jay FRACP, Kurup,Rahul MBBS. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease A Meta-Analysis. ''JAMA Intern Med'', Published online February 01, 2016. doi:10.1001/jamainternmed.2015.7667. |
Revision as of 16:57, 9 February 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
As technology continues to advance, physicians are looking for new ways to engage patients in their own health utilizing smartphone and tablet technology. Multiple randomized control studies have been performed to evaluate whether mobile health has an impact on chronic healthcare conditions, such as diabetes, hypertension, and obesity. The data is mixed, but a several recent trials have shown promise.
Patient Engagement / Participation
Mobile Health
Mobile phone text messaging approximately doubles the odds of medication adherence. A meta- analysis was conducted of 16 randomized control trials to assess the effect of mobile phone text messaging on medication adherence in the setting chronic disease. Study concluded that this intervention improved adherence rates from 50% to 67.8% or an absolute increase of 17.8% (PMID: 26831740).
Mobile health technology has been shown to have a greater reduction in hemoglobin A1c in the setting of diabetes. A randomized controlled trial evaluating the effectiveness of simultaneous mobile health technology in use of diabetes care, when initiating basal insulin therapy, showed a greater reduction in A1c level compared with standard therapy of basal insulin (3.2 ± 1.5% vs. 2.0% ± 2.0%; P = 0.048). This study suggests the use of mobile technology may be an effective form of communication between patients and providers and increase active patient engagement in their health (PMID: 26645932).
References
Hsu, William C. MD. Utilization of a Cloud-Based Diabetes Management Program for Insulin Initiation and Titration Enables Collaborative Decision Making Between Healthcare Providers and Patients. Diabetes Technology & Therapeutics, 18(2), 59-67. DOI: 10.1089/dia.2015.0160.
Thakkar, Jay FRACP, Kurup,Rahul MBBS. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease A Meta-Analysis. JAMA Intern Med, Published online February 01, 2016. doi:10.1001/jamainternmed.2015.7667.